share_log
Breakings ·  Sep 9 13:50
Ascendis Pharma A/S : Evercore ISI Cuts Target Price to $191 From $200
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment